Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 6
Submit an article Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Focus

Papillary fibroelastoma as an occasional finding

Jeroen WalpotDepartment of Cardiology, Ziekenhuis Walcheren, Vlissingen, The Netherlands.Correspondence[email protected]
,
Jetze SorgdragerDepartment of Cardiology, Ziekenhuis Walcheren, Vlissingen, The Netherlands.
,
Martha HoevenaarDepartment of Cardiology, Ziekenhuis Walcheren, Vlissingen, The Netherlands.
&
Cees KlazenDepartment of Cardiology, Ziekenhuis Walcheren, Vlissingen, The Netherlands.
Pages 676-677 | Received 03 Jan 2004, Accepted 04 May 2004, Published online: 23 May 2017

References

  • Tazelaar HD, Locke TJ, Mc Gregor CG. Pathology of sur-gically excised primary cardiac tumours. Mayo ClM Proc 1992; 67: 965–75.
  • Fumero A, Villalba L, Kemeny JL, Camilleri L. Coexisting chordal papillary fibroelastoma and leaflet Lambl’ s tumour of the mitral valve. Interact Cardiovasc Thorac Surg 2003; 2(3): 382–4.
  • Shahian DM. Papillary fibroelastoma. Semin Thorac Car-diovasc Surg 2000; 12(2): 101–10.
  • Ryan PE Jr, Obeid AT, Parker FB Jr. Primary cardiac valve tumors. J Heart Valve Dis 1995; 4: 222–6.
  • Yee HC, Nwosu JE, Lii AD, Velasco M, Millman A. Echocardiographic features of papillary fibroelastoma and their consequences and management. Am J Cardiol 1997; 80: 811–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.